RECURRENT HEPATOCELLULAR CARCINOMA
Clinical trials for RECURRENT HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver cancer drug trial halted after just 3 patients
Disease control TerminatedThis study tested the drug lenvatinib in people whose liver cancer came back after a liver transplant. The goal was to see if the drug could shrink tumors. Only 3 people joined before the study was stopped early, so we have very limited information on how well it works.
Matched conditions: RECURRENT HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Proton beam therapy tested for liver cancer – early results show promise and risks
Disease control TerminatedThis phase II trial tested a precise type of radiation called proton beam therapy in 9 people with liver cancer. The goal was to see if it could control the cancer while limiting damage to the liver. The study was stopped early, so the findings are limited, but early data suggest…
Matched conditions: RECURRENT HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC